Verve Tests First One and Done Gene Editing Treatment for Hereditary Killer 0 12.07.2022 03:00 Feedity.com Verve Therapeutics dosed its first patient with VERVE-101, a one-time treatment that aims to permanently lower low-density lipoprotein (LDL) cholesterol in patients and prevent heart disease. Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа
